US Broker Ratings

The Cigna Group (CI): Investor Outlook on a Healthcare Giant with 26.5% Upside Potential

For investors eyeing opportunities in the healthcare sector, The Cigna Group (NYSE: CI) stands out as a formidable player. With a substantial market capitalization of $79.17..

Natera, Inc. (NTRA) Stock Analysis: Diagnostic Innovator with a 38.79% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a key player in the healthcare sector, operates within the diagnostics and research industry with an impressive market capitalization of $18.97 billion...

UnitedHealth Group (UNH): Valuation Insights and Growth Potential Amidst Healthcare Sector Dynamics

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable player in the healthcare plans industry, with a market capitalization of $254.96 billion. As a cornerstone in..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.95% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, particularly within the diagnostics and research industry, presents a compelling case for investors seeking..

Danaher Corporation (DHR) Stock Analysis: Exploring a 20% Upside in the Healthcare Sector

Danaher Corporation (NYSE: DHR), a major player in the healthcare sector, continues to capture the interest of investors with its robust market presence in the diagnostics..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Investor Insights on a Biotech Giant with 28% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, where its innovative approach to drug development continues to captivate investors and..

Mettler-Toledo (MTD) Stock Analysis: Evaluating Market Position Amidst Challenging Growth Dynamics

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the healthcare sector specializing in diagnostics and research, stands as a significant force in the precision instruments..

Centene Corporation (CNC) Stock Analysis: Exploring a 56% Potential Upside Amid Healthcare Sector Volatility

Centene Corporation (NYSE: CNC), a significant player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to healthcare plans. With a market capitalization..

STERIS plc (STE) Stock Analysis: Healthcare Giant with a 16.51% Potential Upside

STERIS plc (NYSE: STE), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. With a..

Biogen Inc. (BIIB) Investor Outlook: Potential Upside of Over 28% Amidst Diverse Therapeutic Portfolio

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, stands out with its robust therapeutic portfolio targeting neurological and neurodegenerative diseases. With a market cap..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a Potential 41.79% Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the global healthcare sector, specializes in the development, manufacturing, and distribution of generic and specialty medicines...

Alcon Inc. (ALC) Stock Analysis: Eyeing a 14.80% Upside with Strong Buy Consensus

Alcon Inc. (NYSE: ALC), a significant player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its robust portfolio..

Waters Corporation (WAT) Stock Analysis: Exploring a 23.45% Potential Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $18.03..

Zoetis Inc. (ZTS) Investor Outlook: A 27.60% Potential Upside in the Animal Health Market

Zoetis Inc. (NYSE: ZTS), a leading player in the animal health industry, continues to capture investor attention with a promising potential upside of 27.60% based on..

Abbott Laboratories (ABT) Stock Analysis: Healthcare Giant Poised for 12.6% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector with a market capitalization of $220.16 billion, is capturing the attention of investors with its robust..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 2.25% Potential Upside in the Healthcare Sector

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to captivate investor interest with its robust portfolio of human therapeutics and a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a 7.57% Potential Upside Amid Innovations in Biotechnology

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to treating cystic fibrosis (CF)..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 12.43% Upside Potential in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the medical instruments and supplies industry, presents an intriguing opportunity for investors looking to capitalize on the..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Navigating Healthcare Innovation with a 6.28% Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a staggering market capitalization..

GSK plc (GSK) Investor Outlook: Exploring a 8.89% Upside Potential

GSK plc (NYSE: GSK), a stalwart in the global healthcare sector, continues to capture investor interest with its robust portfolio and a potential upside of 8.89%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds